Tag: pharmaceuticals
-
University Licenses Taste-Masking Technology to Pharma
New Jersey Institute of Technology in Newark agreed to license its discoveries that can mask the taste of drug particles to Catalent Pharma Solutions, a drug manufacturer in Somerset, New Jersey. Catalent funded the research by NJIT engineering professor Rajesh Dave (pictured left) that led to the development of this technology. Dave’s research at NJIT…
-
Sanofi, Mass. General to Partner on Cancer Treatments
The global pharmaceutical company Sanofi and Massachusetts General Hospital in Boston agreed to collaborate on translational research into treatments for cancer involving blood and solid (organ-related) tumors. The parties did not disclose financial aspects of the two-year deal. The partnership aims to maximize the strengths of academic and corporate labs; Mass General is a teaching…
-
Universal Prescription Drug Label Standards Issued
The U.S. Pharmacopeial Convention (USP), a scientific standards-setting organization, released new standards that the group says for the first time provide a universal labeling format for medicines in containers dispensed by pharmacists. The standards are expected to be published next month. The standards (free registration required) — known formally as General Chapter <17> Prescription Container…
-
AstraZeneca Licenses Kidney Disease Complications Treatment
AstraZeneca, a global pharmaceutical company based in the U.K., agreed to license a compound to treat complications of chronic and end-stage kidney disease from Ardelyx in Fremont, California. The deal that provides AstraZeneca with an exclusive worldwide license has a value of at least $272.5 million. Ardelyx develops small molecule drugs that restrict absorption in…
-
Immunotherapy Developer Gains $4.9M in Series B Funds
Gliknik Inc., a biopharmaceutical company in Baltimore, raised $4.9 million in series B funds, the second series of financing after initial start-up. Baxter Ventures led the funding round, joined by the company’s existing investors. Gliknik is a developer of therapies for patients with cancer and immune disorders that use the power of the immune system…
-
GE Expands Geron Corp. Stem Cell Licensing Deal
GE Healthcare, a division of General Electric Company, is expanding its licensing agreement with biopharmaceutical company Geron Corp. in Menlo Park, California for stem cell tests used in drug discovery. Financial terms of the deal were not disclosed. In 2009, Geron agreed to license its human embryonic stem cells technology to GE Healthcare for the…
-
Enrollment Begins for Mesothelioma Vaccine Clinical Trial
Aduro BioTech Inc. in Berkeley, California enrolled the first patient in a clinical trial of a therapeutic cancer vaccine to treat malignant pleural mesothelioma. The trial will test the safety and immune response of Aduro BioTech’s CRS-207 vaccine combined with chemotherapy on patients recently diagnosed with the disease. The phase 1B trial is expect to…
-
FDA Approves Colorectal Cancer Treatment
The U.S. Food and Drug Administration approved the drug regorafenib to treat patients with metastatic colorectal cancer, where the cancer has progressed after treatment and spread to other parts of the body. Regorafenib is marketed under the brand name Stivarga by Bayer HealthCare Pharmaceuticals, in Wayne, New Jersey. Stivarga blocks several enzymes that promote cancer…
-
Clinical Trial to Evaluate Type 2 Diabetes Treatments
A clinical trial coordinated by George Washington University in Washington, D.C. will test the effectiveness of glucose-lowering drugs in treating type 2 diabetes. The five year, $134 million study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at National Institute of Health. John Lachin, professor of biostatistics, epidemiology and…
-
Buffalo, Zimbabwe Universities Partner on Nanotech Medicines
University at Buffalo in New York and two universities in the southern African nation of Zimbabwe will collaborate on a new nanotechnology research program in pharmacology. University of Zimbabwe in Harare and the Chinhoyi University of Technology in Mashonaland West, working with Buffalo’s Institute for Lasers, Photonics, and Biophotonics, along with New York State Center…